NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1035 coverProtective Strategies for Neurodegenerative Diseases Volume 1035 published December 2004
Ann. N.Y. Acad. Sci. 1035: 179–196 (2004). doi: 10.1196/annals.1332.012
Copyright © 2004 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by REITER, R. J.
Articles by PAPPOLLA, M. A.
Search for Related Content
PubMed
PubMed Citation
Articles by REITER, R. J.
Articles by PAPPOLLA, M. A.
Melatonin Relieves the Neural Oxidative Burden that Contributes to Dementias

RUSSEL J. REITER, DUN-XIAN TAN AND MIGUEL A. PAPPOLLA

Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA

Address for correspondence: Russel J. Reiter, Ph.D., Department of Cellular and Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, MC 7762, San Antonio, TX 78229-3900. Voice: 210-567-3859; fax: 210-567-3805. reiter{at}uthscsa.edu

This report summarizes some of the many publications that document the beneficial actions of melatonin within the central nervous system. Of particular interest are the multiple functions of melatonin and its metabolites as ubiquitously acting direct free radical scavengers and indirect antioxidants. The fact that melatonin and the metabolic progeny that are formed when it scavenges toxic reactants are all effective in neutralizing destructive molecules greatly increases the efficacy of melatonin as a protection against by-products of oxygen and nitrogen that normally mutilate essential molecules. Of the large number of situations in which oxidative stress may be the cause of disease processes or debilitating conditions, the current review examines melatonin's protection within the central nervous system, particularly in experimental ischemia/reperfusion (stroke) injury, Alzheimer's disease, and parkinsonism. In each of these conditions, melatonin has been found to provide significant neural protection against both the morphophysiological damage and the biobehavioral consequences of these infirmities. The report concludes with the suggestion that melatonin, alone or in combination with other antioxidants, be considered for routine usage to potentially combat some of the neural ravages of aging.

Key Words: melatonin • free radicals • oxidative stress • ischemia/reperfusion • Alzheimer's disease • Parkinson's disease




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
M A Mainster
Violet and blue light blocking intraocular lenses: photoprotection versus photoreception
Br. J. Ophthalmol., June 1, 2006; 90(6): 784 - 792.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. K. LAHIRI, D.-M. CHEN, P. LAHIRI, S. BONDY, and N. H. GREIG
Amyloid, Cholinesterase, Melatonin, and Metals and Their Roles in Aging and Neurodegenerative Diseases
Ann. N.Y. Acad. Sci., November 1, 2005; 1056(1): 430 - 449.
[Abstract] [Full Text] [PDF]



footerLeft footerRight